Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

Clinical trial NCT03107871 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03107871
Sponsor: Albert Park
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cmv Congenital CMV Congenital Cmv SNHL Sensorineural Hearing Loss

Start date: 2018-08-31
Primary completion: 2022-07-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.